Article

Vaccination with a disabled infectious single cycle cytomegalovirus vaccine elicits a distinct glycoprotein B-specific monoclonal antibody repertoire compared to that of naturally-infected individuals

2023-06-23

Abstract excerpt

<title>Abstract</title> <p>Human Cytomegalovirus (HCMV) is the leading infectious congenital infection globally and the most common viral infection in transplant recipients, therefore identifying a vaccine for HCMV is a top priority. Humoral immunity is a correlate of protection for HCMV infection. The most effective vaccine tested to date, which achieved 50% reduction in acquisition of HCMV, was comprised of the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 804524f1-9754-560d-ad8c-8a55c362b105
DOI: 10.21203/rs.3.rs-2985811/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Vaccination with a disabled infectious single cycle cytomegalovirus vaccine elicits a distinct glycoprotein B-specific monoclonal antibody repertoire compared to that of naturally-infected individualsDOI 10.21203/rs.3.rs-2985811/v1Read

The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spreadSemantic proximity Read

Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infectionSemantic proximity Read

Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humansSemantic proximity Read

HCMV glycoprotein B subunit vaccine efficacy was mediated by non-neutralizing antibody effector functionsSemantic proximity Read

Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.Semantic proximity Read

Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protectionSemantic proximity Read

Genetic signatures of human cytomegalovirus variants acquired by seronegative glycoprotein B vaccineesSemantic proximity Read

A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirusSemantic proximity Read

Multivalent Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccines Demonstrate a Greater Breadth in T cell but not Antibody ResponsesSemantic proximity Read

HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functionsSemantic proximity Read

Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccineSemantic proximity Read

A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus.Semantic proximity Read